FRANCIOSO, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 4.626
AS - Asia 1.102
EU - Europa 670
SA - Sud America 235
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 6.664
Nazione #
US - Stati Uniti d'America 4.586
SG - Singapore 524
CN - Cina 205
BR - Brasile 203
IT - Italia 133
RU - Federazione Russa 122
VN - Vietnam 112
HK - Hong Kong 91
DE - Germania 79
IE - Irlanda 55
SE - Svezia 55
FR - Francia 44
JP - Giappone 36
UA - Ucraina 36
GB - Regno Unito 33
FI - Finlandia 31
IN - India 29
PL - Polonia 23
CA - Canada 21
KR - Corea 20
AR - Argentina 16
ES - Italia 12
MX - Messico 12
TR - Turchia 12
AT - Austria 11
BD - Bangladesh 9
IQ - Iraq 9
NL - Olanda 9
ID - Indonesia 8
ZA - Sudafrica 7
EG - Egitto 6
IR - Iran 6
BE - Belgio 5
EC - Ecuador 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
IL - Israele 4
LT - Lituania 4
NG - Nigeria 4
QA - Qatar 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CH - Svizzera 3
CL - Cile 3
DK - Danimarca 3
KE - Kenya 3
NP - Nepal 3
OM - Oman 3
PK - Pakistan 3
SA - Arabia Saudita 3
BG - Bulgaria 2
KH - Cambogia 2
MA - Marocco 2
MN - Mongolia 2
PH - Filippine 2
PY - Paraguay 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GI - Gibilterra 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
LV - Lettonia 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.664
Città #
Wilmington 1.136
Houston 1.024
Woodbridge 779
Singapore 283
San Jose 149
Ashburn 140
Chandler 136
Fairfield 136
Beijing 86
Hong Kong 85
Ann Arbor 78
Seattle 70
New York 59
Los Angeles 58
Rome 57
Cambridge 54
Dublin 48
Ho Chi Minh City 47
Santa Clara 44
The Dalles 40
Council Bluffs 38
Tokyo 35
Medford 30
Jacksonville 28
Hanoi 22
Munich 22
São Paulo 21
Dearborn 19
Buffalo 18
Helsinki 16
Dallas 15
Montreal 15
Nuremberg 15
Engelhard 14
Lauterbourg 14
Lawrence 14
Moscow 14
Palo Alto 12
Orem 11
Warsaw 11
Brooklyn 10
Denver 9
Frankfurt am Main 9
Phoenix 9
Redondo Beach 8
Stockholm 8
Menlo Park 7
Redwood City 7
Suzhou 7
Chicago 6
North Bergen 6
San Diego 6
San Francisco 6
Seoul 6
Turku 6
Atlanta 5
Boardman 5
Brussels 5
Chennai 5
Jakarta 5
Johannesburg 5
Mexico City 5
Poplar 5
Rio de Janeiro 5
St. George 5
Zhengzhou 5
Chandigarh 4
Charlotte 4
Colorado Springs 4
Curitiba 4
Doha 4
Kunming 4
La Veta 4
London 4
Lorton 4
Mumbai 4
Norwalk 4
Reading 4
Salt Lake City 4
Amsterdam 3
Baghdad 3
Biên Hòa 3
Bologna 3
Brno 3
Capurso 3
Caruaru 3
Caxias do Sul 3
Da Nang 3
Erbil 3
Haiphong 3
Hải Dương 3
Las Vegas 3
Manchester 3
Mountain View 3
Muscat 3
Nairobi 3
Paris 3
Ribeirão Preto 3
Sorocaba 3
São José dos Pinhais 3
Totale 5.173
Nome #
Recurrence of insulin resistant metabolic syndrome following liver transplantation 506
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 499
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial 488
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 488
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 475
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 473
Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients 453
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro. 362
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 304
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 298
Evaluation of liver fibrosis in cirrhotic patients: comparison between elastosonography and fibroscan 210
A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications? 203
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 199
Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): longterm results from a single-center 137-patient cohort prospective study 170
Repeated transarterial chemoembolization with degradable starch microspheres (DSMs-TACE) of unresectable hepatocellular carcinoma: A prospective pilot study 146
The acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer in vivo, impairs HBsAg secretion and affects its structural stability in vitro 92
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 91
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 86
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 85
The acquisition of positively charged amino acids in HBsAg C- terminus impairs HBsAg secretion, affects its structural stability and is associated with HBV-induced liver cancer 79
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 76
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 75
Role of Cone-Beam CT in the Intraprocedural Evaluation of Chemoembolization of Hepatocellular Carcinoma 73
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 70
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 70
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 68
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 68
THE ENRICHMENT OF POSITIVELY CHARGED AMINO ACIDS IN HBsAg C-TERMINUS IMPAIRS HBsAg SECRETION, AFFECTS ITS STRUCTURAL STABILITY AND IS CORRELATED WITH HBV-INDUCED LIVER CANCER. 66
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 66
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. 63
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 55
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. 52
HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir 52
HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir 52
Pathways sustaining HDV activity act independently from the size of HBV resevoir and are fueled by an abundant expression of HBsAg from integrated HBV-DNA 52
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. 21
HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential. 21
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. 18
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity 16
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. 16
Intra-hepatic HDV replicative activity can be sustained by HBsAg production from HBV-DNA integration and can modulate virological response to bulevirtide 15
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. 15
HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA 14
Totale 6.801
Categoria #
all - tutte 18.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 31 12
2021/2022203 15 13 24 9 4 16 18 9 13 24 13 45
2022/2023325 22 38 36 43 33 62 22 17 31 3 11 7
2023/2024213 34 8 7 2 9 53 0 5 8 53 1 33
2024/2025734 18 131 57 39 41 68 77 40 80 64 53 66
2025/20261.722 207 72 158 188 163 81 221 188 238 162 44 0
Totale 6.801